Intrathecal drug delivery has been well established an effective and safe method for the treatment of pain, including palliative cancer-related and chronic nonmalignant pain. In this article, we discuss the role of intrathecal pain therapy in the management of chronic, refractory nonmalignant pain. Common indications, patient selection criteria, medication options, complications, and adverse events are discussed within the context of results from randomized controlled trials, clinical consensus guidelines, and best available literature to date.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nec.2018.12.010 | DOI Listing |
Publication Analysis
Top Keywords
intrathecal pain
8
pain therapy
8
therapy management
8
management chronic
8
nonmalignant pain
8
pain
5
chronic noncancer
4
noncancer pain
4
pain intrathecal
4
intrathecal drug
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!